Day 1: FDA Committee meets to discuss the future of Covid vaccines for ages 6 months to 5 years old

On June 14, 2022, under Topic 1, The 2 day meeting the Advisory Committee held met in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to children and adolescents 6 years through 17 years of age.  

On day 2, June 15, 2022, the advisory committee under Topic II, the committee will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age.

Day 2 Meeting:
https://rumble.com/v18sng7-day-2-fda-committee-meets-to-discuss-the-future-of-covid-vaccines-for-ages-.html

Event Documents:
https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-june-14-15-2022-meeting-announcement#event-materials

*Vaccines and Related Biological Products Advisory Committee June 14, 2022 Meeting Draft Roster
https://www.fda.gov/media/159155/download

Vaccines and Related Biological Products Advisory Committee June 14, 2022 Meeting Presentation- COVID19- epidemiology in children and adolescents ages 6 months - 17 years
https://www.fda.gov/media/159222/download

Join Banned Deplorables on Telegram
https://t.me/Banned_Deplorables